Work

RALLY-MF: Initial efficacy of a phase 2 study of DISC-0974, an anti-hemojuvelin antibody, to treat anemia in myelofibrosis.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.6501

Authors: Naseema Gangat, Ayalew Tefferi, Prithviraj Bose, Elizabeth O. Hexner, Laura Christian Michaelis, Aaron Thomas Gerds, Akriti G. Jain, Prioty Islam, Raajit Rampal, Ronan T. Swords, Moshe Talpaz, Kristen M. Pettit, Sima Bhatt, Akshay Buch, Olivia Pelletier, Will Savage, Anna B. Halpern

Institutions: Mayo Clinic, The University of Texas MD Anderson Cancer Center, University of Pennsylvania Health System, Medical College of Wisconsin, Cleveland Clinic, Memorial Sloan Kettering Cancer Center, Oregon Health & Science University, OHSU Knight Cancer Institute, University of Michigan, Disc Medicine, Inc. (United States), University of Washington, Fred Hutch Cancer Center

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162541091

Cites:

Cited by: 2

Related to: